Q4 2024 Holdings
Filed 2025-02-14 | 36 holdings | $361.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $28.2M | 1,025,000 | 7.8% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $27.4M | 692,000 | 7.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $27.3M | 995,000 | 7.5% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $26.7M | 4,390,837 | 7.4% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $21.5M | 7,350,000 | 6.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $18.9M | 9,515,000 | 5.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $18.7M | 451,127 | 5.2% |
| Icon PLC(ICLR) | SHS | G4705A100 | $17.8M | 85,000 | 4.9% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $17.7M | 1,500,000 | 4.9% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $17.7M | 329,768 | 4.9% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $13.9M | 720,500 | 3.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.7M | 1,088,706 | 3.8% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $12.0M | 820,000 | 3.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $11.5M | 1,325,000 | 3.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $8.7M | 920,000 | 2.4% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $8.5M | 80,000 | 2.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.2M | 620,000 | 2.3% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $8.0M | 6,638,935 | 2.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.6M | 305,523 | 2.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $5.8M | 67,000 | 1.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $5.8M | 418,122 | 1.6% |
| Galapagos NVCall | CALL | 36315X901 | $4.9M | 176,900 | 1.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.0M | 3,905,000 | 1.1% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $3.6M | 46,700 | 1.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $3.3M | 55,000 | 0.9% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $3.3M | 908,847 | 0.9% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $3.2M | 70,000 | 0.9% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.2M | 270,000 | 0.9% |
| Erasca Inc(ERAS) | COM | 29479A108 | $2.4M | 947,110 | 0.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.9M | 80,000 | 0.5% |
| Caredx Inc(CDNA) | COM | 14167L103 | $1.7M | 80,000 | 0.5% |
| Mural Oncology PUB LTD Co | ORD SHS | G63365103 | $1.5M | 466,822 | 0.4% |
| Fortrea Hldgs Inc(FTRE) | COMMON STOCK | 34965K107 | $1.0M | 55,100 | 0.3% |
| Aileron Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $931.5K | 404,979 | 0.3% |
| Immunome Inc(IMNM) | COM | 45257U108 | $577.1K | 54,342 | 0.2% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $548.3K | 63,754 | 0.2% |